156 related articles for article (PubMed ID: 11148683)
1. Nonoperative management of hyperparathyroidism: present and future.
Weigel RJ
Curr Opin Oncol; 2001 Jan; 13(1):33-8. PubMed ID: 11148683
[TBL] [Abstract][Full Text] [Related]
2. Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives.
Drüeke TB; Ritz E
Clin J Am Soc Nephrol; 2009 Jan; 4(1):234-41. PubMed ID: 19056615
[TBL] [Abstract][Full Text] [Related]
3. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E
Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031
[TBL] [Abstract][Full Text] [Related]
4. Primary hyperparathyroidism: pathophysiology and impact on bone.
Khan A; Bilezikian J
CMAJ; 2000 Jul; 163(2):184-7. PubMed ID: 10934983
[TBL] [Abstract][Full Text] [Related]
5. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
Grey AB; Stapleton JP; Evans MC; Tatnell MA; Reid IR
Ann Intern Med; 1996 Sep; 125(5):360-8. PubMed ID: 8702086
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. [Calcimimetics--a new treatment for hyperparathyroidism?].
Piecha G; Chudek J; Wiecek A
Pol Merkur Lekarski; 2005 May; 18(107):581-4. PubMed ID: 16161961
[TBL] [Abstract][Full Text] [Related]
8. Primary hyperparathyroidism: Update on presentation, diagnosis, and management in primary care.
Pallan S; Khan A
Can Fam Physician; 2011 Feb; 57(2):184-9. PubMed ID: 21321169
[TBL] [Abstract][Full Text] [Related]
9. Asymptomatic primary hyperparathyroidism: surgical and medical management.
Francucci CM; Ceccoli L; Caudarella R; Rilli S; Vescini F; Boscaro M
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):50-4. PubMed ID: 21985981
[TBL] [Abstract][Full Text] [Related]
10. Persistent elevated serum levels of intact parathyroid hormone after reoperation for primary hyperparathyroidism and after pamidronate therapy.
Darcan S; Coker M; Aydinok Y; Gökşen D; Ozok G
Turk J Pediatr; 2003; 45(3):269-72. PubMed ID: 14696811
[TBL] [Abstract][Full Text] [Related]
11. Cinacalcet HCl: a calcimimetic agent for the management of primary and secondary hyperparathyroidism.
Franceschini N; Joy MS; Kshirsagar A
Expert Opin Investig Drugs; 2003 Aug; 12(8):1413-21. PubMed ID: 12882626
[TBL] [Abstract][Full Text] [Related]
12. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
Torres PU
J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
[TBL] [Abstract][Full Text] [Related]
13. Hyperparathyroidism.
Rude RK
Otolaryngol Clin North Am; 1996 Aug; 29(4):663-79. PubMed ID: 8844736
[TBL] [Abstract][Full Text] [Related]
14. Electrolytes: Calcium Disorders.
Barstow C; Braun M
FP Essent; 2017 Aug; 459():29-34. PubMed ID: 28806048
[TBL] [Abstract][Full Text] [Related]
15. Primary hyperparathyroidism.
Silva BC; Cusano NE; Bilezikian JP
Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):593-607. PubMed ID: 30449543
[TBL] [Abstract][Full Text] [Related]
16. Calcimimetics--new drugs with the potential to control hyperparathyroidism.
Ott SM
J Clin Endocrinol Metab; 1998 Apr; 83(4):1080-2. PubMed ID: 9543121
[No Abstract] [Full Text] [Related]
17. Calcimimetic and Calcilytic Drugs: Feats, Flops, and Futures.
Nemeth EF; Goodman WG
Calcif Tissue Int; 2016 Apr; 98(4):341-58. PubMed ID: 26319799
[TBL] [Abstract][Full Text] [Related]
18. New strategies for the treatment of secondary hyperparathyroidism.
Akizawa T; Shiizaki K; Hatamura I; Kamimura M; Mizobuchi M; Narukawa N; Sumikado S; Sakaguchi T; Negi S; Ogata H; Kinugasa E
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S100-3. PubMed ID: 12612963
[TBL] [Abstract][Full Text] [Related]
19. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
Khan A; Grey A; Shoback D
J Clin Endocrinol Metab; 2009 Feb; 94(2):373-81. PubMed ID: 19193912
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia associated with tertiary hyperparathyroidism managed conservatively with pamidronate in a hemodialysis patient.
Czosnowski LM; Hudson JQ; Canada RB
Am J Med Sci; 2009 Apr; 337(4):300-1. PubMed ID: 19365180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]